Literature DB >> 10407786

Spinal muscular atrophy.

K Talbot1.   

Abstract

Spinal muscular atrophy is a common cause of disability in childhood and is characterized by weakness and wasting of voluntary muscle. It is frequently fatal. The gene for this disorder has been identified as the SMN gene and is part of a highly complex duplicated region of chromosome 5 that is subject to a high rate of gene deletion and gene conversion. The severity of muscle weakness correlates with the amount of full-length SMN protein produced. Molecular genetic studies support a model in which patients are compound heterozygotes of deleted and converted alleles that predicts a progressively decreasing amount of protein product with severity of muscle weakness. The function of SMN is beginning to be understood and it appears to be involved in ribonucleoprotein biogenesis and thus indirectly in post-transcriptional processing of mRNA. There are theoretical grounds for motor neurons having a cell-specific vulnerability to disturbances of mRNA processing and transport and these are briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407786     DOI: 10.1023/a:1005516625866

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  35 in total

1.  Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.

Authors:  L M Brzustowicz; T Lehner; L H Castilla; G K Penchaszadeh; K C Wilhelmsen; R Daniels; K E Davies; M Leppert; F Ziter; D Wood
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

2.  SMN oligomerization defect correlates with spinal muscular atrophy severity.

Authors:  C L Lorson; J Strasswimmer; J M Yao; J D Baleja; E Hahnen; B Wirth; T Le; A H Burghes; E J Androphy
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

3.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

Authors:  P E McAndrew; D W Parsons; L R Simard; C Rochette; P N Ray; J R Mendell; T W Prior; A H Burghes
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism?

Authors:  K Talbot; C P Ponting; A M Theodosiou; N R Rodrigues; R Surtees; R Mountford; K E Davies
Journal:  Hum Mol Genet       Date:  1997-03       Impact factor: 6.150

5.  Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy.

Authors:  H Iwahashi; Y Eguchi; N Yasuhara; T Hanafusa; Y Matsuzawa; Y Tsujimoto
Journal:  Nature       Date:  1997-11-27       Impact factor: 49.962

6.  A novel nuclear structure containing the survival of motor neurons protein.

Authors:  Q Liu; G Dreyfuss
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

7.  Mapping of retrotransposon sequences in the unstable region surrounding the spinal muscular atrophy locus in 5q13.

Authors:  M J Francis; M A Nesbit; A M Theodosiou; N R Rodrigues; L Campbell; Z Christodoulou; S J Qureshi; D J Porteous; A J Brookes; K E Davies
Journal:  Genomics       Date:  1995-05-20       Impact factor: 5.736

8.  De novo and inherited deletions of the 5q13 region in spinal muscular atrophies.

Authors:  J Melki; S Lefebvre; L Burglen; P Burlet; O Clermont; P Millasseau; S Reboullet; B Bénichou; M Zeviani; D Le Paslier
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

9.  Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators.

Authors:  J Melki; P Sheth; S Abdelhak; P Burlet; M F Bachelot; M G Lathrop; J Frezal; A Munnich
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

10.  Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy.

Authors:  N R Rodrigues; N Owen; K Talbot; J Ignatius; V Dubowitz; K E Davies
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

View more
  6 in total

1.  Drug treatment for spinal muscular atrophy types II and III.

Authors:  Renske I Wadman; W Ludo van der Pol; Wendy Mj Bosboom; Fay-Lynn Asselman; Leonard H van den Berg; Susan T Iannaccone; Alexander Fje Vrancken
Journal:  Cochrane Database Syst Rev       Date:  2020-01-06

2.  Treatment of spinal muscular atrophy by sodium butyrate.

Authors:  J G Chang; H M Hsieh-Li; Y J Jong; N M Wang; C H Tsai; H Li
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 3.  RNA processing defects associated with diseases of the motor neuron.

Authors:  Stephen J Kolb; Scott Sutton; Daniel R Schoenberg
Journal:  Muscle Nerve       Date:  2010-01       Impact factor: 3.217

4.  Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs.

Authors:  Peter Claus; Alexander-Francisco Bruns; Claudia Grothe
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

5.  The Burden of Primary Caregivers of Spinal Muscular Atrophy Patients and Their Needs.

Authors:  Ayça Evkaya Acar; Evrim Karadağ Saygı; Sena İmamoğlu; Gülten Öztürk; Olcay Ünver; Pınar Ergenekon; Yasemin Gökdemir; Gülnur Özel; Dilşad Türkdoğan
Journal:  Turk Arch Pediatr       Date:  2021-07-01

6.  Drug treatment for spinal muscular atrophy type I.

Authors:  Renske I Wadman; W Ludo van der Pol; Wendy Mj Bosboom; Fay-Lynn Asselman; Leonard H van den Berg; Susan T Iannaccone; Alexander Fje Vrancken
Journal:  Cochrane Database Syst Rev       Date:  2019-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.